IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Onyx Biotec IPO offer price is ₹ 61.00 and got listed at ₹ 56.75. Read IPO details mentioned above.
Onyx Biotec IPO listing price is ₹ 56.75, issue price is ₹ 61.00, and currently trading at ₹ 57.80 as on 5 march 2025. Infraprime Logistics IPO performance is show below with lates CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Onyx Biotec IPO is a Book Building listing on NSE EMERGE exchange. The company is based in Solan and caters to Pharmaceutical sector. Horizon Management is the merchant banker of Onyx Biotec IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 5th August 2024.
Onyx Biotec IPO offer price is ₹ 61.00 and got listed at ₹ 56.75. Read Infraprime Logistics Technologies IPO details mentioned above.Onyx Biotec IPO, based in Solan, operates in the Pharmaceutical sector with a focus on pharmaceutical company providing sterile water for injections. The company is launching its SME IPO on the NSE EMERGE exchange, using the Book Building Issue method. Onyx Biotec IPO size is ₹ 29.34 Cr. with fresh issue size of ₹ 29.34 Cr. and Offer for sale being Nil
The IPO allotment date for Onyx Biotec IPO is expected to be 19th November 2024, after the finalization of basis of allotment. Investors can check Onyx Biotec IPO allotment status on the registrars website, Mas Services Limited. Onyx Biotec IPO refund dates are 20th November 2024.
Onyx Biotec IPO is expected to be listed on 22nd November 2024.
The upper price band for the Onyx Biotec IPO is set at ₹ 61.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Onyx Biotec IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Onyx Biotec IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 18th November 2024. After submission, funds are blocked until the basis of allotment of Onyx Biotec IPO is finalised.
The merchant banker for Onyx Biotec IPO is Horizon Management Private Limited . Horizon Management Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Onyx Biotec IPO RHP for further details.
The registrar for Onyx Biotec IPO is Mas Services Limited. Investors can go to Mas Services Limited registrar website for IPO allotment status, refund processing, and other queries related to Onyx Biotec IPO through their official website or helpline.
Onyx Biotec IPO was subscribed 198.00 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Listing Gain
Issue Price vs Listing Price:Market Performance
Issue Price vs CMP:Onyx Biotec IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Onyx Biotec Financial Review Page
Merchant Banker(s) of Onyx Biotec IPO: Horizon Management Private Limited
Onyx Biotec IPO subscription was 198.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Onyx Biotec IPO listed at a listing price of 56.75 against the offer price of 61.00.
The current market price of Onyx Biotec is 57.80.
Why Us?
